Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Jacques

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|June 20, 2000
Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinaseF Blanchard, L Duplomb, Y Wang, et al.
Transplantation|March 1, 1989
Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplantation Proceedings|February 1, 1989
Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1992
Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoringJ N Trochu, M Denis, J L Auget, et al.
The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.
The Journal of Biological Chemistry|November 25, 1990
Biochemical study of a recombinant soluble interleukin-2 receptor. Evidence for a homodimeric structureY Jacques, B Le Mauff, A Godard, et al.
FEBS Letters|June 1, 1999
A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130S Pflanz, I Tacken, J Grötzinger, et al.
Transplantation|October 27, 1994
Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivoW M Bogers, F Lang, K E Parker, et al.
Oncogene|August 16, 2006
Loss of oncostatin M receptor beta in metastatic melanoma cellsA Lacreusette, J-M Nguyen, M-C Pandolfino, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|June 20, 2000
Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinaseF Blanchard, L Duplomb, Y Wang, et al.
Transplantation|March 1, 1989
Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplantation Proceedings|February 1, 1989
Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1992
Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoringJ N Trochu, M Denis, J L Auget, et al.
The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.
The Journal of Biological Chemistry|November 25, 1990
Biochemical study of a recombinant soluble interleukin-2 receptor. Evidence for a homodimeric structureY Jacques, B Le Mauff, A Godard, et al.
FEBS Letters|June 1, 1999
A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130S Pflanz, I Tacken, J Grötzinger, et al.
Transplantation|October 27, 1994
Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivoW M Bogers, F Lang, K E Parker, et al.
Oncogene|August 16, 2006
Loss of oncostatin M receptor beta in metastatic melanoma cellsA Lacreusette, J-M Nguyen, M-C Pandolfino, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
Pageof 13